167 related articles for article (PubMed ID: 32474905)
1. HBV-specific CD8 T cells present higher TNF-α expression but lower cytotoxicity in hepatocellular carcinoma.
Zhao L; Jin Y; Yang C; Li C
Clin Exp Immunol; 2020 Sep; 201(3):289-296. PubMed ID: 32474905
[TBL] [Abstract][Full Text] [Related]
2. HBV-specific CD4+ cytotoxic T cells in hepatocellular carcinoma are less cytolytic toward tumor cells and suppress CD8+ T cell-mediated antitumor immunity.
Meng F; Zhen S; Song B
APMIS; 2017 Aug; 125(8):743-751. PubMed ID: 28493520
[TBL] [Abstract][Full Text] [Related]
3. CXCR5
Jin Y; Lang C; Tang J; Geng J; Song HK; Sun Z; Wang J
Int Immunopharmacol; 2017 Dec; 53():42-48. PubMed ID: 29032029
[TBL] [Abstract][Full Text] [Related]
4. CD8
Nandi M; Pal S; Ghosh S; Chakraborty BC; Dey D; Baidya A; Shil A; Chattopadhyaya S; Banerjee S; Santra A; Chowdhury A; Datta S
Clin Sci (Lond); 2019 Sep; 133(17):1917-1934. PubMed ID: 31477625
[TBL] [Abstract][Full Text] [Related]
5. Blocking Tim-3 or/and PD-1 reverses dysfunction of tumor-infiltrating lymphocytes in HBV-related hepatocellular carcinoma.
Liu F; Zeng G; Zhou S; He X; Sun N; Zhu X; Hu A
Bull Cancer; 2018 May; 105(5):493-501. PubMed ID: 29576222
[TBL] [Abstract][Full Text] [Related]
6. Regulation of HBV-specific CD8(+) T cell-mediated inflammation is diversified in different clinical presentations of HBV infection.
Dinney CM; Zhao LD; Conrad CD; Duker JM; Karas RO; Hu Z; Hamilton MA; Gillis TR; Parker TM; Fan B; Advani AH; Poordad FB; Fauceglia PL; Kirsch KM; Munk PT; Ladanyi MP; Bochner BA; Bekelman JA; Grandori CM; Olson JC; Lechan RD; Abou GM; Goodarzi MA
J Microbiol; 2015 Oct; 53(10):718-24. PubMed ID: 26428923
[TBL] [Abstract][Full Text] [Related]
7. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
[TBL] [Abstract][Full Text] [Related]
8. The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.
Raziorrouh B; Schraut W; Gerlach T; Nowack D; Grüner NH; Ulsenheimer A; Zachoval R; Wächtler M; Spannagl M; Haas J; Diepolder HM; Jung MC
Hepatology; 2010 Dec; 52(6):1934-47. PubMed ID: 21064032
[TBL] [Abstract][Full Text] [Related]
9. Decrease of CD69 levels on TCR Vα7.2
Yong YK; Tan HY; Saeidi A; Rosmawati M; Atiya N; Ansari AW; Rajarajeswaran J; Vadivelu J; Velu V; Larsson M; Shankar EM
Innate Immun; 2017 Jul; 23(5):459-467. PubMed ID: 28606013
[TBL] [Abstract][Full Text] [Related]
10. Overrepresentation of IL-10-Expressing B Cells Suppresses Cytotoxic CD4+ T Cell Activity in HBV-Induced Hepatocellular Carcinoma.
Xue H; Lin F; Tan H; Zhu ZQ; Zhang ZY; Zhao L
PLoS One; 2016; 11(5):e0154815. PubMed ID: 27136203
[TBL] [Abstract][Full Text] [Related]
11. Decreased granzyme-B expression in CD11c
Gao L; Hong Z; Lei G; Guo AL; Wang FS; Jiao YM; Fu J
Front Immunol; 2023; 14():1107483. PubMed ID: 36798119
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection.
Nebbia G; Peppa D; Schurich A; Khanna P; Singh HD; Cheng Y; Rosenberg W; Dusheiko G; Gilson R; ChinAleong J; Kennedy P; Maini MK
PLoS One; 2012; 7(10):e47648. PubMed ID: 23112829
[TBL] [Abstract][Full Text] [Related]
13. PD-1
Liu X; Li M; Wang X; Dang Z; Jiang Y; Wang X; Kong Y; Yang Z
Cancer Immunol Immunother; 2019 Dec; 68(12):2041-2054. PubMed ID: 31720814
[TBL] [Abstract][Full Text] [Related]
14. [Expression characteristics of some immune effector molecules in CD8+ T lymphocytes from patients with chronic hepatitis B].
Gao YQ; Yao Y; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1606-9. PubMed ID: 20650779
[TBL] [Abstract][Full Text] [Related]
15. KLRG1-expressing CD8+ T cells are exhausted and polyfunctional in patients with chronic hepatitis B.
Wang L; Liao F; Yang L; Jiang L; Duan L; Wang B; Mu D; Chen J; Huang Y; Hu Q; Chen W
PLoS One; 2024; 19(5):e0303945. PubMed ID: 38776335
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
[TBL] [Abstract][Full Text] [Related]
17. T-bet expression in CD8+ T cells associated with chronic hepatitis B virus infection.
Fan R; Lan Y; Chen J; Huang Y; Yan Q; Jiang L; Song S; Li Y
Virol J; 2016 Jan; 13():14. PubMed ID: 26809262
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-35 Suppresses Interleukin-9-Secreting CD4
Zhang Q; Yang L; Liu S; Zhang M; Jin Z
Front Immunol; 2021; 12():645835. PubMed ID: 34177894
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells.
Hodge G; Barnawi J; Jurisevic C; Moffat D; Holmes M; Reynolds PN; Jersmann H; Hodge S
Clin Exp Immunol; 2014 Oct; 178(1):79-85. PubMed ID: 24894428
[TBL] [Abstract][Full Text] [Related]
20. CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions.
Phillips S; Chokshi S; Riva A; Evans A; Williams R; Naoumov NV
J Immunol; 2010 Jan; 184(1):287-95. PubMed ID: 19949099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
